A lipopeptide based on the M2 and HA proteins of influenza A viruses induces protective antibody (Q43153414)

14 November 2017

title

A lipopeptide based on the M2 and HA proteins of influenza A viruses induces protective antibody (English)

1 reference

14 November 2017

1 reference

5

1 reference

14 November 2017

David Pejoski

1

1 reference

14 November 2017

Weiguang Zeng

series ordinal

2

1 reference

14 November 2017

Steven Rockman

series ordinal

3

1 reference

14 November 2017

Lorena E Brown

series ordinal

4

1 reference

14 November 2017

publication date

23 February 2010

1 reference

Immunology & Cell Biology

14 November 2017

published in

1 reference

14 November 2017

volume

88

1 reference

14 November 2017

issue

5

1 reference

14 November 2017

page(s)

605-611

1 reference

Structural characteristics of the M2 protein of influenza A viruses: evidence that it forms a tetrameric channel

14 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.15

Influenza virus M2 protein has ion channel activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.15

Identification of a second protein (M2) encoded by RNA segment 7 of influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.15

Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.15

Role of the B-cell response in recovery of mice from primary influenza virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.15

Protection against H1, H5, H6 and H9 influenza A infection with liposomal matrix 2 epitope vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.15

Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.15

Monoclonal antibodies recognizing EVETPIRN epitope of influenza A virus M2 protein could protect mice from lethal influenza A virus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.15

Roles of adjuvant and route of vaccination in antibody response and protection engendered by a synthetic matrix protein 2-based influenza A virus vaccine in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.15

Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.15

Influenza type A virus escape mutants emerge in vivo in the presence of antibodies to the ectodomain of matrix protein 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.15

The epitope recognized by a monoclonal antibody in influenza A virus M2 protein is immunogenic and confers immune protection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.15

Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.15

Characterization of immunity induced by M2e of influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.15

A "universal" human influenza A vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.15

Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.15

N-terminus of M2 protein could induce antibodies with inhibitory activity against influenza virus replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.15

Universal influenza A vaccine: optimization of M2-based constructs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.15

A universal influenza A vaccine based on the extracellular domain of the M2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.15

Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.15

The context of epitope presentation can influence functional quality of recalled influenza A virus-specific memory CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.15

A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.15

Characterisation of the antibody response to a totally synthetic immunocontraceptive peptide vaccine based on LHRH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.15

Highly immunogenic and totally synthetic lipopeptides as self-adjuvanting immunocontraceptive vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.15

The central role played by peptides in the immune response and the design of peptide-based vaccines against infectious diseases and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.15

Lipid-containing mimetics of natural triggers of innate immunity as CTL-inducing influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.15

Lipid-based self-adjuvanting vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.15

Conserved determinants for CD4+ T cells within the light chain of the H3 hemagglutinin molecule of influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.15

Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.15

Identification of dominant epitopes of synthetic immunocontraceptive vaccines that induce antibodies in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.15

Induction of long-term memory CD8(+) T cells for recall of viral clearing responses against influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.15

Intranasal lipopeptide primes lung-resident memory CD8+ T cells for long-term pulmonary protection against influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.15

The antibody responses to swine influenza virus (SIV) recombinant matrix 1 (rM1), matrix 2 (M2), and hemagglutinin (HA) proteins in pigs with different SIV exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.15

Identification of peptide sequences that potentially trigger HLA‐A2.1‐restricted cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.15

Electron microscopic evidence for the association of M 2 protein with the influenza virion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.15

Intranasal Vaccination with a Lipopeptide Containing a Conformationally Constrained Conserved Minimal Peptide, a Universal T Cell Epitope, and a Self‐Adjuvanting Lipid Protects Mice from Group A Streptococcus Challenge and Reduces Throat Colonizati

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.15

The C-terminal pentapeptide of LHRH is a dominant B cell epitope with antigenic and biological function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.15

Totally synthetic peptide-based immunocontraceptive vaccines show activity in dogs of different breeds

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.15

Assembly of synthetic peptide vaccines by chemoselective ligation of epitopes: influence of different chemical linkages and epitope orientations on biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.15

Antigenic and immunogenic properties of totally synthetic peptide-based anti-fertility vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.15

Dendritic Cell Immunotherapy of Hepatitis C Virus Infection: Toxicology of Lipopeptide-Loaded Dendritic Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.15

The M2 ectodomain is important for its incorporation into influenza A virions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.15

inferred from DOI database lookup

7 January 2021

based on heuristic

Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.15

inferred from DOI database lookup

7 January 2021

based on heuristic

Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.15

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/ICB.2010.15

1 reference

Dimensions Publication ID

14 November 2017

1045030905

0 references

1 reference